HHS Permits Compounding Pharmacies to Produce Six Unapproved Peptides

The Department of Health and Human Services has issued a new policy allowing compounding pharmacies to manufacture six specific peptides not yet approved by the FDA. This decision impacts patient access to these substances and fuels ongoing discussions regarding the regulatory oversight of compounded medications.